BUSINESS
Bayer’s Progress on Roundup Woes Won’t End Monsanto Headache - BNN Bloomberg
BUSINESS

Bayer’s Progress on Roundup Woes Won’t End Monsanto Headache - BNN Bloomberg

Published: May 26, 2020  |  4 min read, 831 words
WRITTEN BY
Your review will affect the following:
{{data.symbol | reutersRICLabelFormat:group.RICS}}{{data.netChng | number: 4 }}{{data.netChng | number: 2 }}{{data.price | number: 4 }}{{data.price | number: 2 }}Continuous Play:The information you requested is not available at this time, please check back again soon.(Bloomberg) -- Bayer AG is close to a turning point in its legal battle over the weedkiller Roundup. But it still has work to do to convince investors that buying Monsanto made sense.The German drug and agriculture giant reached verbal agreements to resolve tens of thousands of U.S. cancer lawsuits over its Roundup weedkiller,... READ MORE
CRITIC
N/A
N/Ano rating
Critic Reviews: N/A
We calculate ratings after a minimum of three reviews.
USER
N/A
N/Ano rating
User Reviews: N/A
We calculate ratings after a minimum of three reviews.
TOP REVIEWS
There are no reviews yet.

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.